The 2024–26 parliamentary session has seen significant activity across health and social care, with a number of key legislative developments now shaping the future of the sector.
Following the end of the 2024-26 parliamentary session, our latest report provides a clear and concise overview of three major pieces of health legislation that progressed during that session: the Rare Cancers Act 2026, the Terminally Ill Adults (End of Life) Bill, and the Tobacco and Vapes Act 2026.
In this report, we explore:
– The objectives behind each piece of legislation
– Stakeholder perspectives and areas of debate
– The potential impact on public health and patient safety
To download the full report, simply fill out the form below:
Our latest research
The 2024–26 parliamentary session has seen significant activity across health and social care, with a number of key legislative developments now shaping the future of the sector. Following the end of the 2024…
On 7 May 2026, voters across England will choose new councils in elections that could produce a more unsettled political landscape than we have seen for some time. That matters not only because control may shif…
Introduction On Friday 24 April, after 18 months of intense scrutiny and extensive debate, the Terminally Ill Adults (End of Life) Bill finally ended its legislative journey without passing into law. The bill w…
New insights from the next generation of policy thinkers As part of our ongoing collaboration with Queen Mary University of London and the Mile End Institute, Dods Political Intelligence is proud to champion em…
Britain’s intergenerational compact is under serious strain. A new report from Dods Research finds that across student finance, housing, labour market outcomes, and long-term savings, Generation Z face st…
On Thursday 7 May, voters in Wales and Scotland will elect representatives to their respective devolved administrations. With significant shifts in political momentum following the 2024 general election, these …